Tirbanibulin

Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma

A Phase 3, Multicentre, Randomised, Double-blind, Vehicle-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Tirbanibulin 10 mg/g Ointment Applied to a Treatment Field Larger Than 25 cm2 and up to 100 cm2 in Adult Patients With Actinic Keratosis

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face

Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands

Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)